BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 22, 2019
View Archived Issues
Anti-RSV agent ziresovir demonstrates promising preclinical profile
Read More
PDX model allows study of hepatitis B virus in hepatocellular carcinoma
Read More
Targeting NuRD for derepression of fetal hemoglobin in hemoglobinopathies
Read More
MSH3 linked to somatic expansion and disease phenotype in Huntington's disease and DM1
Read More
First patient enrolled in phase II study of AR-201 for egg allergy
Read More
MyoKardia initiates dosing in phase I study of MYK-224 for hypertrophic cardiomyopathy
Read More
Glenmark receives approval for combination of remogliflozin and metformin in India
Read More
Phase I data presented for CM-101 subcutaneous formulation
Read More
Shinkei Therapeutics files IND application with the FDA for MR-201
Read More
Discovery of novel antisense oligonucleotides for the treatment of prion disease
Read More
Discovery and preclinical evaluation of SH-379 as a novel anti-LOH agent
Read More
Results presented from phase III HOPE study of voxelotor in sickle cell disease
Read More
Eisai describes new aldehyde dehydrogenase-2 activators
Read More
Bruton tyrosine kinase inhibitors discovered at Merck & Co.
Read More
Pfizer identifies Gly12Cys mutant GTPase KRas inhibitors
Read More
Placental growth factor may be autoimmune disease target
Read More
Sichuan Kelun-Biotech Biopharmaceutical patents C-C chemokine receptor type 2/5 antagonists
Read More
Shenzhen Bo Li Jian Medicine discloses new mutant EGFR inhibitors
Read More
Japanese approval for Darzalex in newly diagnosed multiple myeloma
Read More
China's NMPA approves roxadustat for anemia in patients with CKD not receiving dialysis
Read More
Lonsurf approved in Japan for advanced gastric cancer
Read More
Could orphan opioid receptor prevent opioid orphans?
Read More
Identifying the cause of lupus cognitive dysfunction
Read More
